AI funding is easing as lower credit-insurance costs could reopen funding. CoreWeave CDS fell to ~1,040bp from above 1,100bp; Oracle says growth should fund itself from FY29. Google kept its $195–205B 2026 capex guide, expects more in 2027 and is renting third-party compute despite margin headwinds, supporting Nebius and CoreWeave pricing power. Microsoft’s Azure growth accelerated to 48%, while Meta and Microsoft credit spreads eased. A bigger rally needs further credit easing. x.com  x.com  … Show more

AI product, networking, compute and power demand could reward patient owners of Meta, Nokia, Oracle, Broadcom, IREN and Vistra. Meta's Muse could unlock massive revenue; free cash flow could recover when AI spending slows. Nokia works with Nvidia on AI-RAN and 6G. Oracle has $664B in obligations and massive potential reward from OpenAI. Broadcom's AI chip revenue rose 221% to $16.7B; IREN has a $9.7B Microsoft contract and 5 GW of power. AI power bottlenecks favor Vistra. x.com  x.com  x.com  x.com  … Show more

Heavy AI-related borrowing with little to show for it is pressuring Oracle, IREN and Nebius shares. These stocks are beginning to trend lower. x.com 

Nebius' software efficiency and a possible end to heavy AI financing support a re-rating. Per @DrTomsLens, its engineers got about 43% more video output from the same GPUs, cutting compute cost per second by 30%; newer hardware alone is not enough without capable software teams. Oracle expects to fund growth from free cash flow in FY2029, suggesting capital-heavy AI providers may eventually outgrow debt and dilution. Google Cloud reported 103% revenue growth amid strong AI infrastructure demand. … Show more

Oracle looks mispriced because $11 of current consolidated earnings power puts it at 11x earnings without a breakup. It trades below its software business's value despite the highest gross retention in software; separating pre-AI OCI, AI operations and AI development makes it an obvious long. Future funding will cost more, but current leverage is no issue and all contracts are well below spot, leaving nowhere near neocloud risk. Fundamentals may not matter during panics. x.com  x.com  x.com 

Oracle's OpenAI exposure makes buying its shares here a bet too big to take. x.com  x.com 

These 12 stocks offer exposure to AI, automation, health care, consumer growth and nuclear demand. AMD makes AI chips; Oracle builds AI cloud; Vertex has multiple drug opportunities. Arista supplies data-center switches, KLA inspection tools and Cadence chip-design tools. Palantir sells AI platforms; Symbotic automates warehouses; Alphabet spans search, cloud and AI. Celsius has US consumer momentum, AppLovin runs high-margin mobile ads, and Cameco mines uranium and co-owns Westinghouse. x.com  … Show more

Oracle's plan to fund its AI buildout from cash flow makes last week's financing fears look completely overdone. It expects capex to peak in FY27-28, free cash flow to turn positive in H2 FY28 and top $30B in FY29, funding growth from then. Oracle plans at most $20B in further capital raises through FY30, excluding refinancing, after an already completed $20B equity raise. Vendor financing, customer prepayments and customer-supplied hardware should reduce upfront cash needs. x.com  x.com 

Oracle's reliance on OpenAI makes its backlog vulnerable. About $250B of backlog comes from OpenAI, which is not making money; that risk is no longer in Oracle's hands, and the stock is very likely to fall further. x.com  x.com 

Oracle's AI buildout looks fundable as spending peaks and cash flow turns positive. Spending is forecast to peak in FY27-28, with free cash flow positive in 2H FY28 and above $30bn in FY29, a roughly $54bn swing. New capital raising is capped at $20bn through 2030, half equity and half debt. Revenue is projected to grow from $90bn next year to $225bn+ by FY30. Bullish Oracle. x.com